| Name | Title | Contact Details |
|---|
Meet Woebot, your personal mental health ally that helps you get back to feeling like yourself. Backed by clinical research, powered by AI.
Playvox`s powerfully simple workforce engagement management (WEM) solutions transform customer care. We deeply understand that exceptional employee engagement produces extraordinary customer experiences, and we love creating tools that help our customers unlock the full potential in every employee and every interaction. Playvox powers the world`s fastest-growing brands. Our agent-empowering suite of workforce management, quality assurance, performance, learning, customer AI, and gamification lives seamlessly in the modern support operations ecosystem with tools like Amazon Connect, Salesforce, Slack, ServiceNow, and Zendesk.
Code Climate, maker of the Engineering Management Platform Velocity, is trusted by thousands of organizations – from enterprises to startups – to optimize return on investment in software engineering. Code Climate was founded in 2011 by engineering leaders who were frustrated by decisions being made in the dark or by gut instinct. After nearly a decade helping over 100,000 developers improve the quality and maintainability of their codebases with their automated code review tool, Quality, Code Climate launched their flagship product Velocity, enabling technology leaders to make better informed – and therefore better – management decisions. Velocity delivers impact from day one, giving organizations insight into how their engineering resources are allocated, automated flags for delivery risks and bottlenecks, and internal and external benchmarking. Using Velocity, engineering leaders can align their team structure and resources to strategic priorities, intervene early to prevent delivery delays, and take targeted steps to improve their team`s productivity and performance.
Save up to $1000/year with fiber internet – and keep your live TV.
Harnessing the power of the regulatory genome to create highly selective, next-generation molecular therapies